Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits

INTRODUCTION: Expanded access is the use of an investigational product by patients with serious medical conditions without participation in a clinical trial. It is a complicated process involving the collaboration of many parties and pharmaceutical companies. Ongoing efforts focus on accelerating ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Fountzilas, Elena, Said, Rabih, Tsimberidou, Apostolia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291242/
https://www.ncbi.nlm.nih.gov/pubmed/29353505
http://dx.doi.org/10.1080/13543784.2018.1430137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291242/
https://www.ncbi.nlm.nih.gov/pubmed/29353505
http://dx.doi.org/10.1080/13543784.2018.1430137

Ejemplares similares